Inmed to participate in upcoming investor events

Vancouver, british columbia--(newsfile corp. - march 6, 2023) - inmed pharmaceuticals inc. (nasdaq: inm) ("inmed" or the "company"), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced the company's executive team will be participating in the upcoming virtual investor events throughout march 2023: emerging growth conference date: march 8, 2022 time: 12:30 pm et registration: https://goto.webcasts.com/starthere.jsp?ei=1595542&tp_key=9ac5970e97&sti=inm inmed's ceo, mr. eric a. adams, will present a corporate overview followed by a questions and answers session.
INM Ratings Summary
INM Quant Ranking